Evidence map›Paper›PMID 29499272›Full record

ArticleNeuropharmacology2018

Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.

Landon M Klein, Nicholas V Cozzi, Paul F Daley, Simon D Brandt, Adam L Halberstadt

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Moving beyond 5-HTPsychopharmacology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)The Journal of pharmacology and experimental therapeutics · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Effect ofFrontiers in psychiatry · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Landon M KleinDepartment of Neurosciences, University of California San Diego, La Jolla, CA, USA.
Nicholas V CozziDepartment of Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; The Alexander Shulgin Research Institute, Lafayette, CA, USA.
Paul F DaleyThe Alexander Shulgin Research Institute, Lafayette, CA, USA.
Simon D BrandtThe Alexander Shulgin Research Institute, Lafayette, CA, USA; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, UK.
Adam L HalberstadtDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA; Research Service, VA San Diego Healthcare System, San Diego, CA, USA. Electronic address: ahalberstadt@ucsd.edu.
University of California San Diego · USLiverpool John Moores University · GBUniversity of Wisconsin–Madison · US

Funding

The Next Generation of Hallucinogens: A New Class of Synthetic Psychoactive DrugsR01DA041336 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HALBERSTADT, ADAM L. · 2017 to 2020
$1.4M
NIDA NIH HHS R01 DA041336
6 · The paper itself

Abstract

Substantial effort has been devoted toward understanding the psychopharmacological effects of tryptamine hallucinogens, which are thought to be mediated by activation of 5-HT

Indexed as

AnimalsGuinea PigsHallucinogensHead MovementsHumansIllicit DrugsMaleMice, Inbred C57BLNeurotransmitter AgentsProtein BindingRatsReceptors, NeurotransmitterTryptaminesHallucinogensIllicit DrugsNeurotransmitter AgentsReceptors, NeurotransmitterTryptamines4-Acetoxy-N,N-diallyltryptamine4-AcO-DALT4-Hydroxy-N,N-diallyltryptamine5-MeO-DALT5-Methoxy-N,N-diallyltryptamineHallucinogenHead twitchMicePsychedelic

Identifiers

PMID29499272
PMCPMC6230509
OpenAlexW2789608017

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.